UPDATE : Friday, July 3, 2020
상단여백
Crystal Genomics to start P2 trial of Covid-19 treatment by Lee Han-soo 2020-07-02 18:07
Boryung finds cancer drug has antiviral effect on Covid-19 by Shim Hyun-tai 2020-07-02 18:07
Heliximith unveiled how HX109 inhibits prostate hyperplasia by Lee Han-soo 2020-07-02 15:03
MSD Korea reshuffles personnel before spinoff of Organon by Kim Yun-mi 2020-07-02 13:44
Novartis’ asthma drug gets insurance benefit by Shim Hyun-tai 2020-07-01 20:05
라인
Takeda Korea completes takeover of Shire Korea by Lee Han-soo 2020-07-01 17:39
Hanmi to export dyslipidemia drug to Mexico via MSD by Shim Hyun-tai 2020-07-01 14:19
Hanmi's short bowel syndrome treatment wins rare pediatric disease status by Lee Han-soo 2020-06-30 17:38
Hugel submits NDA for BTX product in Europe by Lee Han-soo 2020-06-30 15:36
KPBMA to expand local drugmakers’ exchanges with Europe by Kim Chan hyuk 2020-06-30 14:09
라인
Bukwang to change clinical design for Covid-19 drug candidate by Kim Chan-hyuk 2020-06-30 13:18
Samsung Bioepis’ drug to join bevacizumab biosimilar competition in Europe by Kim Chan hyuk 2020-06-29 16:08
Vivozon to start P3b trial of nonnarcotic analgesics in US by Lee Han-soo 2020-06-26 17:13
Helixmith pushes ahead with P3-2 trial for neuropathic pain treatment by Lee Han-soo 2020-06-26 16:38
Celltrion tops pharmaceutical brand reputation in June by Park Gi-taek 2020-06-26 15:23
라인
10 more Korean drugmakers nestle in Boston to enter US market by Kim chan-hyuk 2020-06-26 14:12
Alteogen signs $3.8-billion tech transfer deal with a global pharma by Shim Hyun-tai 2020-06-25 16:19
‘Use NEWS score system to detect high-risk Covid-19 patients early’ by Song Soo-youn 2020-06-25 15:07
Hanmi, Novartis in patent dispute over diabetes drug by Kim Yun-mi 2020-06-25 13:59
Hanmi Science Presents 6 Great Visions for Post COVID-19 by Lee Han-soo 2020-06-24 18:02
여백
여백
여백
Back to Top